Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer in the Elderly Journal of Clinical Oncology, 04/25/2012

Cuffe S et al. – Uptake of adjuvant chemotherapy for non–small–cell lung cancer (NSCLC) increased in patients age 70years or older following reporting of pivotal adjuvant chemotherapy trials, but it remained below that for patients younger than age 70years. Adoption of adjuvant chemotherapy appears to be associated with significant survival benefit in the elderly (age ≥70years), with tolerability apparently similar to that of patients who are younger than age 70years.

Read this article on Journal of Clinical Oncology

Print Article | Back to Articles

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Medical Student Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?